OTC · Financial Statements
Genscript Biotech Corporation (GNNSF) Financial Statements
$3.08
OTC: GNNSF
Market Cap $6.73B
Overview Financials Dividend Genscript Biotech Corporation most recently reported annual revenue of $961.0M, net profit of $-534.0M, revenue has compounded at 19.7% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $511.0M $626.0M $840.0M $594.0M $961.0M Operating Profit $-368.0M $-436.0M $-416.0M $9.0M $256.0M Net Profit $-359.0M $-227.0M $-95.0M $3.0B $-534.0M EPS $-0.18 $-0.11 $-0.05 $1.36 $-0.25 Op Margin -72.1% -69.7% -49.5% 1.6% 26.6%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $2.2B $2.5B $3.4B $5.3B $4.9B Total Liabilities $1.1B $1.2B $1.3B $955.0M $876.0M Cash $1.2B $1.0B $1.4B $132.0M $174.0M Borrowings $156.0M $350.0M $417.0M $171.0M $609.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-137.0M $-120.0M $-287.0M $76.0M $326.0M Investing Cash Flow $-350.0M $-647.0M $-515.0M $-1.6B $-256.0M Financing Cash Flow $0 $-37.0M $-12.0M $8.0M $-11.0M Net Cash Flow $552.0M $-157.0M $422.0M $-1.3B $10.0M Free Cash Flow $-274.0M $-324.0M $-445.0M $-72.0M $242.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 21.45 FCF Yield 3.59% Quick Ratio 1.41 Interest Coverage 31.48 Return 1Y 69.42% Return 3Y 69.42% Return 5Y -7.00%
Screens featuring this stock